Supernus Pharmaceuticals
SUPN
SUPN
165 hedge funds and large institutions have $725M invested in Supernus Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
9% more call options, than puts
Call options by funds: $3.52M | Put options by funds: $3.23M
Holders
165
Holding in Top 10
8
Calls
$3.52M
Puts
$3.23M
Top Buyers
| 1 | +$25M | |
| 2 | +$23.4M | |
| 3 | +$21.2M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$19.1M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$10.8M |
Top Sellers
| 1 | -$51.1M | |
| 2 | -$43.1M | |
| 3 | -$27.8M | |
| 4 |
MRM
Michael R. Murphy
|
-$13.1M |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$11.9M |